Investor Relations
Investors
Liberty Defense is working toward a safer future, secure from acts of violent crime and terrorism, by developing next generation threat detection using disruptive technology to detect concealed weapons.
Nasdaq
DETX
TSX Venture
SCAN
Quotes are delayed.
Financial reports
Financial statements and MD&A
Access our annual and quarterly financial statements and management’s discussion and analysis documents.
2026
| Q2 Financial Statement | Period ended June 30, 2026 |
| Q2 MD&A | Period ended June 30, 2026 |
| Q1 Financial Statement | Period ended March 31, 2026 |
| Q1 MD&A | Period ended March 31, 2026 |
2025
| Q4 Financial Statement | Period ended December 31, 2025 |
| Q4 MD&A | Period ended December 31, 2025 |
| Q3 Financial Statement | Period ended September 30, 2025 |
| Q3 MD&A | Period ended September 30, 2025 |
| Q2 Financial Statement | Period ended June 30, 2025 |
| Q2 MD&A | Period ended June 30, 2025 |
| Q1 Financial Statement | Period ended March 31, 2025 |
| Q1 MD&A | Period ended March 31, 2025 |
2024
| Q4 Financial Statement | Period ended December 31, 2024 |
| Q4 MD&A | Period ended December 31, 2024 |
| Q3 Financial Statement | Period ended September 30, 2024 |
| Q3 MD&A | Period ended September 30, 2024 |
| Q2 Financial Statement | Period ended June 30, 2024 |
| Q2 MD&A | Period ended June 30, 2024 |
| Q1 Financial Statement | Period ended March 31, 2024 |
| Q1 MD&A | Period ended March 31, 2024 |
2023
| Q4 Financial Statement | Period ended December 31, 2023 |
| Q4 MD&A | Period ended December 31, 2023 |
| Q3 Financial Statement | Period ended September 30, 2023 |
| Q3 MD&A | Period ended September 30, 2023 |
| Q2 Financial Statement | Period ended June 30, 2023 |
| Q2 MD&A | Period ended June 30, 2023 |
| Q1 Financial Statement | Period ended March 31, 2023 |
| Q1 MD&A | Period ended March 31, 2023 |
2022
| Q4 Financial Statement | Period ended December 31, 2022 |
| Q4 MD&A | Period ended December 31, 2022 |
| Q3 Financial Statement | Period ended September 30, 2022 |
| Q3 MD&A | Period ended September 30, 2022 |
| Q2 Financial Statement | Period ended June 30, 2022 |
| Q2 MD&A | Period ended June 30, 2022 |
| Q1 Financial Statement | Period ended March 31, 2022 |
| Q1 MD&A | Period ended March 31, 2022 |
2021
| Q4 Financial Statement | Period ended December 31, 2021 |
| Q4 MD&A | Period ended December 31, 2021 |
| Q3 Financial Statement | Period ended September 30, 2021 |
| Q3 MD&A | Period ended September 30, 2021 |
| Q2 Financial Statement | Period ended June 30, 2021 |
| Q2 MD&A | Period ended June 30, 2021 |
| Q1 Financial Statement | Period ended March 31, 2021 |
| Q1 MD&A | Period ended March 31, 2021 |
2020
| Q4 – Financial Statement | Period ended December 31, 2020 |
| Q4 – MD&A | Period ended December 31, 2020 |
| Q3 – Financial Statement | Period ended September 30, 2020 |
| Q3 – MD&A | Period ended September 30, 2020 |
| Q2 – Financial Statement | Period ended June 30, 2020 |
| Q2 – MD&A | Period ended June 30, 2020 |
| Q1 – Financial Statement | Period ended March 31, 2020 |
| Q1 – MD&A | Period ended March 31, 2020 |
2019
| Annual Financial Statement | Period ended March 12, 2020 |
| Annual MD&A | Period ended March 12, 2020 |
| Q3 – Financial Statement | Period ended November 7, 2019 |
| Q3 – MD&A | Period ended November 7, 2019 |
| Q2 – Financial Statement | Period ended August 1, 2019 |
| Q2 – MD&A | Period ended August 1, 2019 |
| Q1 – Financial Statement | Period ended May 16, 2019 |
| Q1 – MD&A | Period ended May 16, 2019 |
2018
| Annual Financial Statement | Period ended March 5, 2019 |
| Annual MD&A | Period ended March 5, 2019 |
| Q3 – Financial Statement | Period ended November 29, 2018 |
| Q3 – MD&A | Period ended November 29, 2018 |
| Q2 – Financial Statement | Period ended August 29, 2018 |
| Q2 – MD&A | Period ended August 29, 2018 |
| Q1 – Financial Statement | Period ended May 30, 2018 |
| Q1 – MD&A | Period ended May 30, 2018 |
2017
| Annual Financial Statement | Period ended April 30, 2018 |
| Annual MD&A | Period ended April 30, 2018 |
| Q3 – Financial Statement | Period ended November 29, 2017 |
| Q3 – MD&A | Period ended November 29, 2017 |
| Q2 – Financial Statement | Period ended August 28, 2017 |
| Q2 – MD&A | Period ended August 28, 2017 |
| Q1 – Financial Statement | Period ended May 29, 2017 |
| Q1 – MD&A | Period ended May 29, 2017 |
2016
| Annual Financial Statement | Period ended April 20, 2017 |
| Annual MD&A | Period ended April 20, 2017 |
| Q3 – Financial Statement | Period ended November 29, 2016 |
| Q3 – MD&A | Period ended November 29, 2016 |
| Q2 – Financial Statement | Period ended August 25, 2016 |
| Q2 – MD&A | Period ended August 25, 2016 |
| Q1 – Financial Statement | Period ended May 31, 2016 |
| Q1 – MD&A | Period ended May 31, 2016 |
2015
| Annual Financial Statement | Period ended April 17, 2016 |
| Annual MD&A | Period ended April 17, 2016 |
| Q3 – Financial Statement | Period ended December 2, 2015 |
| Q3 – MD&A | Period ended December 2, 2015 |
| Q2 – Financial Statement | Period ended August 28, 2015 |
| Q2 – MD&A | Period ended August 28, 2015 |
| Q1 – Financial Statement | Period ended May 26, 2015 |
| Q1 – MD&A | Period ended May 26, 2015 |
2014
| Annual Financial Statement | Period ended April 27, 2015 |
| Annual MD&A | Period ended April 27, 2015 |
| Q3 – Financial Statement | Period ended November 27, 2014 |
| Q3 – MD&A | Period ended November 27, 2014 |
| Q2 – Financial Statement | Period ended August 27, 2014 |
| Q2 – MD&A | Period ended August 27, 2014 |
| Q1 – Financial Statement | Period ended May 29, 2014 |
| Q1 – MD&A | Period ended May 29, 2014 |
2013
| Annual Financial Statement | Period ended April 8, 2014 |
| Annual MD&A | Period ended April 8, 2014 |
| Q3 – Financial Statement | Period ended November 26, 2013 |
| Q3 – MD&A | Period ended November 26, 2013 |
| Q2 – Financial Statement | Period ended August 29, 2013 |
| Q2 – MD&A | Period ended August 29, 2013 |
| Q1 – Financial Statement | Period ended June 13, 2013 |
| Q1 – MD&A | Period ended June 13, 2013 |
Stock information
Share structure and warrants
Shares outstanding, warrants and stock quotes for Nasdaq: DETX and TSXV: SCAN.
Upcoming events
Events
Conferences, webcasts and the annual meeting are announced by news release and email alert.
Corporate governance
Governance documents
Investor contacts
Email alerts
Get Liberty Defense news and investor updates by email.
You can unsubscribe at any time from the link at the bottom of every email.
